Pharma stocks gain, as Trump’s tariff move actually could be a win for the sector
Short excerpt below. Click through to read at the original source.
Pharmaceutical stocks mostly gained Friday, as traders appeared to shrug off or even cheer President Donald Trump’s rollout of a new tariff plan for drugmakers.